[1]姜 飞,王东玉.依达拉奉右莰醇联合尿激酶静脉溶栓治疗急性脑梗死合并糖尿病对患者血清氧化应激水平、颈总动脉内-中膜厚度、血清基质金属蛋白酶-12水平的影响[J].陕西医学杂志,2022,51(1):88-91.[doi:DOI:10.3969/j.issn.1000-7377.2022.01.023]
　JIANG Fei,WANG Dongyu.Effects of edaravone dexborneol combined with urokinase intravenous thrombolysis on serum oxidative stress,common carotid artery intra-media thickness and serum MMP-12 in patients with acute cerebral infarction and diabetes mellitus[J].,2022,51(1):88-91.[doi:DOI:10.3969/j.issn.1000-7377.2022.01.023]
点击复制

依达拉奉右莰醇联合尿激酶静脉溶栓治疗急性脑梗死合并糖尿病对患者血清氧化应激水平、颈总动脉内-中膜厚度、血清基质金属蛋白酶-12水平的影响
分享到：

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
51
期数:
2022年1期
页码:
88-91
栏目:
药物与临床
出版日期:
2022-01-05

文章信息/Info

Title:
Effects of edaravone dexborneol combined with urokinase intravenous thrombolysis on serum oxidative stress,common carotid artery intra-media thickness and serum MMP-12 in patients with acute cerebral infarction and diabetes mellitus
作者:
姜 飞; 王东玉
(锦州医科大学 锦州市中心医院研究生培养基地,辽宁 锦州 121000)
Author(s):
JIANG Fei; WANG Dongyu
(Graduate Training Base,Jinzhou Central Hospital,Jinzhou Medical University,Jinzhou 121000,China)
关键词:
急性脑梗死;  糖尿病;  依达拉奉右莰醇;  尿激酶静脉溶栓;  氧化应激;  基质金属蛋白酶-12
Keywords:
Acute cerebral infarction;  Diabetes mellitus;  Edaravone dexborneol;  Urokinase intravenous thrombolysis;  Oxidative stress;  Matrix metalloproteinase-12
分类号:
R 743
DOI:
DOI:10.3969/j.issn.1000-7377.2022.01.023
文献标志码:
A
摘要:
目的:研究依达拉奉右莰醇联合尿激酶静脉溶栓对急性脑梗死(ACI)合并糖尿病患者血清氧化应激水平、颈总动脉内-中膜厚度(IMT)、血清基质金属蛋白酶-12(MMP-12)水平的影响。方法:选取90例ACI合并糖尿病患者随机分为溶栓组和抗氧化组,每组各45例,溶栓组患者在常规治疗基础上使用尿激酶静脉溶栓治疗,抗氧化组使用依达拉奉右莰醇联合尿激酶静脉溶栓治疗,两组患者均治疗2周,比较两组患者治疗前和治疗2周后神经功能[美国国立卫生研究院卒中量表(NIHSS)]、脑血流动力学指标[最小血流量(Qmin)、最小血流速度(Vmin)]、颈动脉超声指标[IMT、颈总动脉收缩期内径(Ds)、颈总动脉舒张期内径(Dd)]、血清氧化应激水平[丙二醛(MDA)、超氧化物歧化酶(SOD)、去甲肾上腺素(NE)]、炎症指标[C反应蛋白(CRP)、MMP-12、血清基质金属蛋白酶-9(MMP-9)]。比较治疗2周内两组患者药物不良反应发生率。结果:治疗2周后,两组患者Qmin、Vmin、SOD水平显然高于治疗前,抗氧化组显著高于溶栓组(均P<0.05); MDA、NE、IMT、Ds、Dd、CRP、MMP-12、MMP-9水平和NIHSS评分显然低于治疗前,抗氧化组显著低于溶栓组(均P<0.05)。治疗2周内,两组药物不良反应发生率比较无统计学差异(P>0.05)。结论:依达拉奉右莰醇联合尿激酶静脉溶栓治疗ACI合并糖尿病患者可有效缓解患者机体氧化应激反应,改善脑部血流和颈动脉超声指标,且安全性良好。
Abstract:
Objective:To study the effects of edaravone dexborneol combined with urokinase intravenous thrombolysis on serum oxidative stress level,common carotid artery intra-media thickness(IMT)and serum matrix metalloproteinase-12(MMP-12)level in patients with acute cerebral infarction(ACI)complicated with diabetes mellitus.Methods:90 patients with ACI and diabetes mellitus were selected and randomly divided into thrombolysis group and antioxidation group,with 45 cases in each group.The thrombolysis group was given urokinase intravenous thrombolysis on the basis of conventional treatment,and the antioxidation group was treated with edaravone dexborneol combined with urokinase intravenous thrombolysis,and both groups were treated for 2 weeks.The neurological function indicator [National Institutes of Health Stroke Scale(NIHSS)],cerebral hemodynamic indicators [minimum blood flow volume(Qmin),minimum blood flow velocity(Vmin)],carotid ultrasound indicators [common carotid artery intra-media thickness(IMT),common carotid artery systolic diameter(Ds),common carotid artery diastolic diameter(Dd)],serum oxidative stress indicators [Malondialdehyde(MDA),Superoxide dismutase(SOD),norepinephrine(NE)] and inflammatory indicators [C-reactive protein(CRP),MMP-12,MMP-9] of the two groups before treatment and after 2 weeks of treatment were compared.The incidence rates of adverse drug reactions within 2 weeks of treatment were compared between the two groups.Results:After 2 weeks of treatment,the Qmin,Vmin and SOD of the two groups were significantly higher than those before treatment,and the three indicators of antioxidation group were significantly higher than those of thrombolysis group(all P<0.05).The MDA,NE,IMT,Ds,Dd,CRP,MMP-12,MMP-9 and NIHSS score were obviously lower than those before treatment,and the above indicators in antioxidation group were significantly lower than those in thrombolysis group(all P<0.05).Within 2 weeks of treatment,there were no significant differences in the incidence rates of adverse drug reactions between the two groups(all P>0.05).Conclusion:Edaravone dexborneol combined with urokinase intravenous thrombolysis for patients with ACI and diabetes mellitus can effectively alleviate the body's oxidative stress response,and improve the cerebral blood flow and carotid ultrasound parameters,with good safety.

参考文献/References:

[1] 杜茜茜,杨 铭.醒脑开窍针刺法联合西医常规治疗对糖尿病合并亚急性期脑梗死患者神经功能,血脂,炎症因子及血糖的影响[J].陕西中医,2021,42(4):523-526.
[2] 薛亚妮,刘 瑞,陈 彭,等.依达拉奉注射液联合阿替普酶静脉溶栓治疗急性脑梗死临床疗效观察[J].陕西医学杂志,2021,50(6):731-734.
[3] 范文博,王 琳,李 强.2型糖尿病合并急性脑梗死患者外周血中性粒细胞与淋巴细胞比值的临床意义[J].中国免疫学杂志,2018,34(6):915-918.
[4] 范勤毅,干 静,王晓蓉,等.抗氧化药物添加治疗急性脑梗死合并2型糖尿病的疗效观察[J].中风与神经疾病杂志,2018,35(2):131-135.
[5] 郭鑫儒,李炜宾.丁苯肽注射液联合依达拉奉治疗急性脑梗死的疗效观察[J].山西医药杂志,2018,47(2):203-204.
[6] 付享征,金 玲,沈 洁.急性脑梗死与糖尿病临床关系探讨[J].中国临床保健杂志,2005,8(4):359-360.
[7] 蔡业峰,贾 真,张新春,等.美国国立卫生院卒中量表(NIHSS)中文版多中心测评研究——附537例缺血中风多中心多时点临床测评研究[J].北京中医药大学学报,2008,31(7):494-498.
[8] 王珊珊.氯吡格雷对急性脑梗死合并糖尿病患者疗效及血清血管活性因子、血小板活化参数的影响[J].山东医药,2019,1139(17):57-59.
[9] 曾培灿,肖颖秀,曾宪杰,等.前列地尔联合阿替普酶治疗急性脑梗合并糖尿病疗效观察[J].西南国防医药,2018,28(12):25-27.
[10] 谭道富,富士峰,唐友琼.通窍活血汤加减联合尤瑞克林对急性脑梗死合并糖尿病患者的疗效及VEGF的影响[J].辽宁中医杂志,2020,514(3):146-149.
[11] 陈 彬,徐成婷,沈 伟.胞二磷胆碱联合尿激酶治疗急性脑梗死的临床研究[J].现代药物与临床,2018,33(12):3123-3127.
[12] 贝 筝,陈 怡,龙登毅,等.丁苯酞联合依达拉奉治疗急性脑梗死患者神经功能及血管内皮功能的影响[J].脑与神经疾病杂志,2019,27(1):7-11.
[13] 孙永康,刘建涛,郑树然,等.复元醒脑汤联合依达拉奉对2型糖尿病合并急性缺血性脑卒中血管内皮功能、神经功能缺损的影响[J].辽宁中医杂志,2020,523(12):105-108.
[14] 邵 元,陈孔博.丁苯酞联合依达拉奉治疗急性脑梗死的临床分析[J].山西医药杂志,2019,48(11):33-35.
[15] 王献胜,王 伟,刘凤兰,等.依达拉奉联合丁苯酞对急性脑梗死患者的影响研究[J].实用心脑肺血管病杂志,2018,26(3):109-111.
[16] 李 俊,庞洪波,胡 勇,等.丁苯酞氯化钠注射液联合依达拉奉对急性脑梗死患者神经功能及日常生活能力的影响[J].贵阳医学院学报,2018,43(7):812-815.
[17] 吴 强,吕晓影,张乐国.血浆脂蛋白相关磷脂酶A2、超敏C反应蛋白联合载脂蛋白E检测在脑梗死诊断中的应用价值[J].中南医学科学杂志,2019,47(1):40-43.
[18] 郑丽娜.神经节苷脂+阿司匹林+阿托伐他汀三联疗法对脑梗死患者氧化应激及炎症反应的影响[J].海南医学院学报,2018,24(1):117-120.
[19] 刘兴中,朱高平,郑智琴,等.尿激酶对急性脑梗死患者血管内皮功能及氧化应激的影响及疗效观察[J].现代生物医学进展,2019,19(21):153-157.
[20] 肖 静,谭郎敏,潘成德,等.rt-PA静脉溶栓与尿激酶静脉溶栓治疗急性脑梗死的疗效比较研究[J].解放军预防医学杂志,2018,36(4):441-444,450.
[21] 詹骐魁,叶胜业,林 森,等.依达拉奉治疗急性脑梗死的临床疗效及对氧化应激和炎症因子的影响[J].贵州医药,2018,42(7):50-52.
[22] 魏 欣,白向东.依达拉奉联合丁苯肽治疗急性脑梗死的疗效观察[J].宁夏医科大学学报,2009,133(01):95-96.
[23] 杨运芳.依达拉奉在急性期脑梗死患者中的有效性及安全性分析[J].实用心脑肺血管病杂志,2018,26(S2):82-84.
[24] 李福军,陈 可,马海玲,等.依达拉奉联合银杏二萜内酯对老年急性脑梗死患者的影响[J].实用心脑肺血管病杂志,2019,27(2):93-96.
[25] 王丽华.依达拉奉治疗急性脑梗死的临床研究[J].卒中与神经疾病,2020,15(3):177-177.
[26] 周红艳,刘云华,周成芳.依达拉奉联合奥扎格雷钠治疗急性进展性脑梗死的疗效观察与护理[J].中南医学科学杂志,2011,39(06):713-715.
[27] 黄赛忠,严立平,屠明锋.依达拉奉联合血栓通治疗急性进展性脑梗死36例[J].陕西中医,2011,32(2):144-145.

相似文献/References:

[1]李福泰,姚春虹△,慕廷民,等.急性脑梗死患者炎症因子与同型半胱氨酸、纤维蛋白原相关性研究*[J].陕西医学杂志,2019,(1):71.
　LI Futai,YAO Chunhong,MU Tingmin,et al.Correlation study between inflammatory factors andhomocysteine and fibrinogen in acute cerebral infarction patients[J].,2019,(1):71.
[2]袁山旗,赵红敏△,张西安,等.机械支架介入取栓联合静脉溶栓治疗老年急性脑梗死临床疗效 及对患者神经功能的影响[J].陕西医学杂志,2019,(2):237.
　YUAN Shanqi,ZHAO Hongmin,ZHANG Xian,et al.Clinical study of mechanical stent intervention and thrombectomy combined with arteriovenous thrombolysis in〖JP〗 the treatment of acute cerebral infarction in the elderly and its effect on neurological function[J].,2019,(1):237.
[3]冯金艳,邱丽华.MRI检查对颈动脉粥样硬化斑块的诊断价值研究*[J].陕西医学杂志,2019,(4):467.
　FENG Jinyan,QIU Lihua..Diagnostic value of MRI examination for carotid atherosclerotic plaques[J].,2019,(1):467.
[4]陆俊杰,张 洋,张清清,等.经微导管注射替罗非班联合Solitaire支架取栓治疗急性脑梗死21例临床研究*[J].陕西医学杂志,2019,(6):740.
[5]武卫党,石 磊,张丹凤△,等.达格列净对糖尿病心肌缺血大鼠心肌功能改善作用的实验研究*[J].陕西医学杂志,2020,49(7):778.[doi:DOI:10.3969/j.issn.10007377.2020.07.003]
[6]杨 鲲,何 勇△,孙 静.比伐卢定与普通肝素对冠心病合并2型糖尿病患者经皮冠状动脉介入术凝血功能的影响研究*[J].陕西医学杂志,2020,49(9):1157.[doi:DOI:10.3969/j.issn.1000-7377.2020.09.026]
　YANG Kun,HE Yong,SUN Jing..Effect of bivalirudin and unfractionated heparin on coagulation function in patients with coronary heart disease complicated with type 2 diabetes mellitus undergoing PCI[J].,2020,49(1):1157.[doi:DOI:10.3969/j.issn.1000-7377.2020.09.026]
[7]廖 涛,刘 超△.触珠蛋白与急性脑梗死患者病情程度及预后相关性分析[J].陕西医学杂志,2020,49(10):1292.[doi:DOI:10.3969/j.issn.1000-7377.2020.10.024]
[8]杨 旭,张致英,康龙丽,等.环状RNA与代谢性疾病研究进展[J].陕西医学杂志,2021,50(1):126.[doi:DOI:10.3969/j.issn.1000-7377.2021.01.033]
　YANG Xu,ZHANG Zhiying,KANG Longli,et al.Advances in circular RNA and metabolic diseases[J].,2021,50(1):126.[doi:DOI:10.3969/j.issn.1000-7377.2021.01.033]
[9]俞 茜,冯天保,王晓慧,等.磁共振成像平扫、磁敏感加权成像诊断急性脑梗死临床价值对比研究[J].陕西医学杂志,2021,50(4):425.[doi:DOI:10.3969/j.issn.1000-7377.2021.04.010]
[10]包 蕾.阿加曲班联合阿司匹林治疗急性脑梗死疗效及对患者血管内皮功能的影响[J].陕西医学杂志,2021,50(5):603.[doi:DOI:10.3969/j.issn.1000-7377.2021.05.022]
　BAO Lei.Efficacy of agatroban combined with aspirin in treatment of acute cerebral infarction[J].,2021,50(1):603.[doi:DOI:10.3969/j.issn.1000-7377.2021.05.022]

更新日期/Last Update: 2022-01-09